• No results found

Mass Serialization and Traceability Implementation in the Pharma Industry. Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland

N/A
N/A
Protected

Academic year: 2021

Share "Mass Serialization and Traceability Implementation in the Pharma Industry. Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland"

Copied!
17
0
0

Loading.... (view fulltext now)

Full text

(1)

Mass Serialization and Traceability

Implementation in the Pharma Industry

Mathieu Aman, Global Program Lead

(2)

What drives the industry towards more “traceability”

Strategic thinking & a long-term vision required

Roche's roadmap

(3)

An ongoing focus towards more control & security in todays’ global Pharma Supply Chains

The Importance of Packaging is Increasing in Pharma

3 Product security

Patient safety through Barcoding & a safer Product Identification

Process integrity & Transaction security

with Traceability at Sales Unit level

E-supply-chain & Digitization

as a transformational and sustainable trend

Regulators Customers Global Supply Chain

Threats / Challenges Brand Protection

External drivers Internal drivers

SC visibility & Control

counterfeits

diversion

theft

bed-side scanning

avoid medication error

5 patient’s rights

mobile computing authentication

chain of custody / accountability

protect industry reputation

combat re-imbursement fraud

supply chain visibility

trust

recall effectiveness

m-health / e-services

e-leaflet

mobile computing authentication

(4)

An ongoing focus towards more control & security in todays’ global Pharma Supply Chains

The Importance of Packaging is Increasing in Pharma

4 Product security

Patient safety through Barcoding & a safer Product Identification

Process integrity & Transaction security

with Traceability at Sales Unit level

E-supply-chain & Digitization

as a transformational and sustainable trend

Regulators Customers Global Supply Chain

Threats / Challenges Brand Protection

External drivers Internal drivers

SC visibility & Control

MAH’s responsibility:

Increase Confidence & Demonstrate evidence that

product is safe & secure from manufacturing till it reaches the patient

Building in intelligence and

sophisticated features into

primary & secondary packaging “Interactive” packaging

(5)

The outcome: the sales units gets unique and tamper-proof A unique number to identify each single tamper-proof sales pack

5 Human Readable Information Tamper Evidence Material Number GTIN / NTIN Data Carrier Machine readable Serial Number

• A unique number assigned

to a single unit

• A randomized numeric code

Level 1: 2D -CO DIN G and SERIAL IZATIO N new new new Overt/Covert Anti-Counterfeiting features

(6)

What drives the industry towards more traceability

Strategic thinking & a long-term vision required

Roche's roadmap

(7)

Strategic thinking & a long-term vision 2009 Vision ideal state 2 3 1 Roche approach:

Vision + backward planning

What we didn’ t want: «Classical» Incremental approach Tota l En ter prise P erforma nce Proof-of-concept Ramp-Up/ Deploy

Maximize Biz. Value

2010 2013 2016 French Coding E-pedigree Korea SER EU VPD Brazil T&T TE … 7 Scale FAST Start SMALL Think BIG

(8)

8 Where do we see this journey going…

Do not focus on one specific requirement; Instead, put in perspective

I III Technical security measures Serialization

& Tamper Evidence

Traceability

Secure e-Supply Chain

In ve stme nt le ve l

From Product Security… … to Transaction Security & Digitization

< 2010 2015 2020

IV

E-services M- services

II

The country maps indicate what the country targets as of today

(9)

• A cross functional global effort

ensure standardization, interoperability and integration

Strong global drive & close cooperation with local implementation teams / SME’s

This is not only a technical project

• Develop and implement an adaptable/scalable technical standard solution

Co-develop with vendor

A constant mix of prototyping, conceptual design and operational implementation

• Work together with other stakeholders

authorities, standard bodies, associations, peers, trading partners, vendors…

Strategic thinking & a long-term vision What our approach is from beginning

9

Accept the challenge as an opportunity

(10)

What drives the industry towards more traceability

Strategic thinking & a long-term vision required

Roche's roadmap

(11)

A long term effort 2009 2011 2013 2015 D2 D1 2010 Phase II

Ramp-up & fulfill mid-term requirements

Phase I

Proof-of-concept, built a working infrastructure (E2E) & fulfill short term requirements

EU, US timelines known. Define implementation pace Decision taken to ramp-up Prepare implementation roadmap Foundation in place 2012 2014 2016+

BUILDING THE INFRASTRUCTURE WHILE FULFILLING REGULATIONS

Packaging line upgrade Phase O Strategy defined, prepare execution Kick-off Imple me ntati on Effort We are here 11 MAXIMIZING BUSINESS VALUE

(12)

As a consequence, we have to upgrade all packaging lines and build a new IT-infrastructure while ensuring continuous supply

Line Server Automation Unit Case Automation Unit Palett Automation Unit Serialization Automation Unit Primary Line Network Plant Server Consider line/site switches

Build bridging stocks in alignment between supply planning-site planning team

Consider workarounds e.g. offline printing Coordination of various

vendors requiring strong and robust planning under

consideration of capacity bottleneck at OEM vendors Regulatory developments with impact on program timelines

Roche supply constraints

The “PHYSICAL WORLD”

(13)

It is not only about line upgrades & IT tools !

People & Functions are impacted, requiring a strong change management

Manage Demand Produce Quality Product Assess & Release Material Manage Logistics & Distribution

De m an d S up ply Packaging Development Artworks Change Coordination Master Data Management

Supply Chain: Materials Management, Planning Packaging Operations Information Technology QA/QC Warehousing Operator DC Operator Commercial Operations  Maintain country/regulatory requirement database in master data / BoM / recipe

 Maintain Product # / GTIN in master data (MDMS, MLS)  Manage artworks

change

 Print/verify Product # on pack

 Transmit serial # ranges to MLS, LC

 Print/verify Serial # on pack  Collect serial # from MLS,

LC and transmit to OER  EDI – interface monitoring

 QC-testing & grading acceptance criteria  Manage serialized

samples

 Manage deviations / OoS

 Create ASN to trading partner  Report data to MoH database

 Manage customer’s

authentication request  Manage delivery of serialized/

aggregated products in warehouse

 Transfer serialized products between CoE/CMO and DC’s  Exception handling in warehouse  Exception handling in DC Ne w se rial izat io n pr ocesse s Impac ted fu nct io ns 13 QA/QC Change management

(14)

What drives the industry towards more traceability

Strategic thinking & a long-term vision required

Roche's roadmap

(15)

What’s next ? E-leaflet ?

App for patient verification

Onboarding of HC actors by continuous scope extension See the example of Turkey’s implementation roadmap

In scope

40’000 Stakeholders

• Hospitals • Health Centers

• Family Physician Centers

• Pharmacies and Pharmacy Warehouses • Manufacturers

• Importers

• Reimbursement Institutions

Figures & Facts today

Number of drug types in İTS: 18 900 Number of drug unıts in İTS: 7 000 000 000 Number of daily operations in İTS: 45 000 000 Number of operations per second in İTS: 520 Response time of system: < 1 sec

ROI in ONE YEAR! 15

E-prescription / e-invoicing

Tracking & Tracing

Verification at dispensing + scanning based Re-imbursement

Barcoding & Item Serialization

All Health providers

Patients Pharmacists Wholesalers Pharma Industry ??? 2013 2014 2011 2012 2010 2015+ ?

Apply 2D Barcode / Technical features MoH builds IT infrastructure & Database Onboard & Connect Onboard & Connect Reach out to public

The same can currently be observed in Argentina & in Korea (live since 2010/2013)

(16)

Applying a 2D Barcode on the packs is just the

beginning of the journey… and it’s not only about

Traceability

16

(17)

References

Related documents

Keywords: Alzheimer’s disease, artificial neural networks, feedforward, MRI, image attributes, texture, frequency, Fourier Transform, Discrete Wavelet Transform, GLCOM,

In contrast, the target colour was correctly identified in trials without competing distractors (Desimone, Wessinger, Thomas, &amp; Schneider, 1990). In sum, the

Our aim in this paper is to start from the simple formulation of a one-period pay-as-clear market, and propose a pay-as-bid type market, in which limit prices different for

Além das amostras (odores corporais) colocadas em frascos de plástico com tampa de enroscar, usados para recolha de urina pelos laboratórios de análises clínicas e que se aplicam

The central idea is highlight the fundamental concepts of the complex Least       Absolute Shrinkage and Selection Operator (c-LASSO) and give an overview of       its application

Oils – Petroleum – (See Type) Oleic Acid Oxalic Acid Palmitic Acid 10% Perchloric Acid 10% Phenylhydrazine Hydrochloride Phosgene, Gas Phosphoric Acid – 0-25% Phosphoric Acid –

Safe use for neuropathic pain (central and peripheral), complex pain, migraine, and the evidence for some non-neuropathic pain conditions will be discussed, as well as the

It takes the historical schema as input and allows one, among others, to (1) compare two arbitrary schema versions, (2) extract the database schema at a given date, (3) extract